HEALTH Minister Greg Hunt has announced a revamp of the Life Saving Drugs Program (LSDP), with new procedures including an expanded criteria for medicines to both extend life and improve the quality of a patient's life.
A new independent panel will support the chief medical officer in considering applications, with Hunt saying the changes would mean pharmaceutical companies have a clearer path for assessment.
Medicines Australia welcomed the changes, with ceo Milton Catelin particularly highlighting the impact of medicines that reduce the level and duration of disability.
The above article was sent to subscribers in Pharmacy Daily's issue from 29 Jan 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Jan 18
